Now, Russia says its new Covid-19 vaccine Sputnik V is showing over a 92% success rate

The Sputnik V vaccine is developed at the National Research Centre for Epidemiology and Microbiology (NRCEM) in Moscow and is currently going through phase III clinical trials in multiple countries.

[Via]

Sign Up for NextBigWhat Newsletter

Daily.

You May Also Like